MACK

Merrimack Pharmaceuticals, Inc.

Delisted

MACK was delisted on the 17th of May, 2024.

135 hedge funds and large institutions have $663M invested in Merrimack Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-15
Holders Change %
-10%
% of All Funds
3.77%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
55
Reduced
43
Closed
26
Calls
$4.05M
Puts
$2.43M
Net Calls
+$1.62M
Net Calls Change
-$2.39M
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
151
Renaissance Technologies
New York
-$212K -2,175 Closed
QIM
152
Quantitative Investment Management
Virginia
-$166K -1,716 Closed
HF
153
HRT Financial
New York
-$142K -1,468 Closed
SG Americas Securities
154
SG Americas Securities
New York
-$127K -1,303 Closed
TDC
155
Thompson Davis & Co
Virginia
-$124K -1,271 Closed
Lazard Asset Management
156
Lazard Asset Management
New York
-$85K -881 Closed
Simplex Trading
157
Simplex Trading
Illinois
-$78K -807 Closed
SSB
158
Sandy Spring Bank
Maryland
-$10K -102 Closed
BRWM
159
B. Riley Wealth Management
Tennessee
-$6K -64 Closed
FANJ
160
Financial Architects (New Jersey)
New Jersey
-$6K -64 Closed
JG
161
Jefferies Group
New York
-$1K -11 Closed